These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


151 related items for PubMed ID: 3024645

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Paradoxical effects of K+ and D-600 on parathyroid hormone secretion and cytoplasmic Ca2+ in normal bovine and pathological human parathyroid cells.
    Larsson R, Akerström G, Gylfe E, Johansson H, Ljunghall S, Rastad J, Wallfelt C.
    Biochim Biophys Acta; 1985 Nov 20; 847(2):263-9. PubMed ID: 4063399
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Relationship between external and cytoplasmic calcium concentrations, parathyroid hormone release and weight of parathyroid glands in human hyperparathyroidism.
    Wallfelt C, Gylfe E, Larsson R, Ljunghall S, Rastad J, Akerström G.
    J Endocrinol; 1988 Mar 20; 116(3):457-64. PubMed ID: 3351432
    [Abstract] [Full Text] [Related]

  • 6. Hyperparathyroidism is associated with reduced expression of a parathyroid calcium receptor mechanism defined by monoclonal antiparathyroid antibodies.
    Juhlin C, Klareskog L, Nygren P, Ljunghall S, Gylfe E, Rastad J, Akerström G.
    Endocrinology; 1988 Jun 20; 122(6):2999-3001. PubMed ID: 2836180
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mechanism of the hypocalcemic agent WR-2721 and its acute and chronic application in eu- and hyperparathyroidism.
    Hirschel-Scholz S, Caverzasio J, Bonjour JP.
    Adv Exp Med Biol; 1986 Jun 20; 208():367-70. PubMed ID: 3031946
    [No Abstract] [Full Text] [Related]

  • 12. Parathyroid tissue in normocalcemic and hypercalcemic primary hyperparathyroidism recruited by health screening.
    Lundgren E, Ridefelt P, Akerström G, Ljunghall S, Rastad J.
    World J Surg; 1996 Sep 20; 20(7):727-34; discussion 735. PubMed ID: 8678973
    [Abstract] [Full Text] [Related]

  • 13. Ga3+ inhibits parathyroid hormone release without interacting with the Ca2+ receptor of the parathyroid cell.
    Ridefelt P, Hellman P, Ljunggren O, Ljunghall S, Akerström G, Rastad J, Gylfe E.
    Biochem Biophys Res Commun; 1992 Jul 15; 186(1):556-61. PubMed ID: 1321615
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Kinetic evidence for cytoplasmic calcium as an inhibitory messenger in parathyroid hormone release.
    Wallfelt C, Lindh E, Larsson R, Johansson H, Rastad J, Akerström G, Gylfe E.
    Biochim Biophys Acta; 1988 May 13; 969(3):257-62. PubMed ID: 3370224
    [Abstract] [Full Text] [Related]

  • 16. Stimulating parathyroid cell proliferation and PTH release with phosphate in organ cultures obtained from patients with primary and secondary hyperparathyroidism for a prolonged period.
    Nakajima K, Umino K, Azuma Y, Kosaka S, Takano K, Obara T, Sato K.
    J Bone Miner Metab; 2009 May 13; 27(2):224-33. PubMed ID: 19194773
    [Abstract] [Full Text] [Related]

  • 17. Prevention of parathyroid hormone-dependent nephrocalcinosis by chronic administration of the organic phosphorothioate WR-2721.
    Hirschel-Scholz S, Caverzasio J, Bonjour JP.
    Calcif Tissue Int; 1987 Feb 13; 40(2):103-8. PubMed ID: 3032378
    [Abstract] [Full Text] [Related]

  • 18. Fluoride interactions with stimulus-secretion coupling of normal and pathological parathyroid cells.
    Ridefelt P, Hellman P, Rastad J, Larsson R, Akerström G, Gylfe E.
    Acta Physiol Scand; 1992 Jul 13; 145(3):275-85. PubMed ID: 1325732
    [Abstract] [Full Text] [Related]

  • 19. Microfluorometric measurements of cytoplasmic calcium in chief and oxyphil parathyroid cells of adenomatous and hyperplastic glands and of normal-sized glands associated with adenomas.
    Johansson H, Rastad J, Bjerneroth G, Gylfe E, Akerström G.
    Surgery; 1989 Sep 13; 106(3):517-24. PubMed ID: 2772827
    [Abstract] [Full Text] [Related]

  • 20. Suppression of parathyroid secretion after administration of WR-2721 in a patient with parathyroid carcinoma.
    Hirschel-Scholz S, Jung A, Fischer JA, Trechsel U, Bonjour JP.
    Clin Endocrinol (Oxf); 1985 Sep 13; 23(3):313-8. PubMed ID: 3000652
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.